Asthma Clinical Guidelines
“In many parts of the world, asthma remains under-diagnosed and under-treated, leading to poor quality of life, and enormous social, family, and economic costs. In many low income countries such as Kenya, there are no public supported asthma care programs designed to optimize care for patients with asthma which greatly compounds the diagnosis and treatment problems […] By improving the access and quality of asthma care services provided by health care providers both in public and private health care settings, it is hoped that ultimately, the lives of patients with asthma will be changed.”
In January 2011, the Ministry of Health and Social Welfare (MOHSW) in Kenya published clinical guidelines for asthma management. The Guidelines were developed by the Division of Leprosy, Tuberculosis, and Lung Disease at the MOHSW, in collaboration with the Kenya Association for the Prevention of Tuberculosis and Lug Diseases (KAPTLD).
The Guidelines were based on a synthesis of international guidelines such as materials produced by the Global Initiative for Asthma (GINA) and International Union Against TB and Lung Disease (The Union), adapted for use in the Kenyan context through a consultative process.
The Asthma Guidelines booklet includes sections on:
- Asthma definition, disease burden, and risk factors
- Asthma pathogenesis and pathophysiology
- The diagnosis of asthma
- Medications used in asthma
- Management of asthma
- Organization and delivery of asthma care services
- Monitoring and evaluation of asthma care programs
The development of the Guidelines was supported by unrestricted funding provided by GlaxoSmithKline (GSK), Astra Zeneca (AZ), and Lords Health Care.